Results 151 to 160 of about 2,546,422 (186)

Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data [PDF]

Statistical Journal of the IAOS: Journal of the International Association for Official Statistics, 2012
As the core health expenditure survey in the United States, the Medical Expenditure Panel Survey (MEPS) is increasingly being used by statistical agencies to track expenditures by disease. However, while MEPS provides a wealth of data, its sample size precludes examination of spending on all but the most prevalent health conditions.
Ana Aizcorbe, Eli Liebman, Sarah Pack, David M. Cutler, Michael E. Chernew, Allison B. Rosen   +5 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Abstract 20172: Identifying Hospital Cardiac Services for Acute Myocardial Infarction Using Individual Patient Claims Data

Circulation, 2014
Background: Hospital data on cardiac services provided is restricted to a limited number of services collected by the American Hospital Association (AHA) Survey. We developed an alternative method to identify hospital services using individual patient administrative claims data for acute myocardial infarction (AMI) in the ...
Tiffany E Chang, Shu-Xia Li, Isuru Ranasinghe, Harlan Krumholz   +3 more
openaire   +1 more source

All-Payer Claims Databases: The Balance between Big Healthcare Data Utility and Individual Health Privacy

SSRN Electronic Journal, 2017
As policymakers pursue the Triple Aim of reducing costs, improving quality, and expanding access, the development of an All-Payer Claims Database (APCD) can provide invaluable information about the drivers of cost, the value of health care interventions, and the efficacy of policy initiatives.
Jaime S. King, Andrew Kelly
openaire   +1 more source

Abstract 12665: Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals With Diagnosed and Undiagnosed Familial Hypercholesterolemia

Circulation, 2022
Introduction: Individuals with Familial Hypercholesterolemia (FH) warrant intensive lipid lowering therapy starting with statins and adding ezetimibe and PCSK9 inhibitors (PCSK9i) as needed to achieve LDL-C treatment targets. Little data exists on whether disparities exist in the US FH population for ezetimibe, PCSK9i or the ...
Zahid Ahmad, Chao Xing, Amit Khera, Chun-Yuan Huang, Eric Brandt, Dianne MacDougall, Catherine D Ahmed, Mary P McGowan, Katherine A Wilemon, Kelly Myers   +9 more
openaire   +1 more source

[Once vaccinated, always vaccinated? A claims data analysis on repeated influenza vaccinations among individuals aged ≥ 60 years].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2023
The Standing Committee on Vaccination recommends the seasonal influenza vaccination as a standard vaccination for individuals aged ≥ 60 years and as an indication vaccination independent of age. Empirical data on repeated vaccination are not available for Germany.
Josephine, Storch, Franziska, Meissner, Monique, Böde, Anja, Kwetkat, Mathias W, Pletz, Antje, Freytag   +5 more
openaire   +1 more source

Comparing Two Approaches to Identify Individuals with Severe Asthma in United States Claims Data

Pharmacoepidemiology and Drug Safety
ABSTRACT Purpose Given the increased likelihood for individuals with severe asthma to experience comorbidities, disease complications, emergency room visits, and hospitalizations, the ability to stratify asthma populations on severity is often important.
Julie Barberio, Xinyu Li, Sarah‐Jo Sinnott   +2 more
openaire   +1 more source

Individual Claims Generator for Claims Reserving Studies: Data Simulation.R

SSRN Electronic Journal, 2022
Melantha Wang, Mario V. Wuthrich
openaire   +1 more source

Using Healthcare Claims Data to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial Hypercholesterolemia

AbstractBackgroundIndividuals with familial hypercholesterolemia (FH) require intensive lipid-lowering therapy, starting with high-intensity statins and adding ezetimibe and PCSK9 inhibitors (PCSK9i) as needed to reach target LDL-C levels. There are limited data on disparities in the use of these therapies among individuals with FH in the US.MethodsWe ...
Mary P. McGowan, Chao Xing, Amit Khera, Chun-Yuan Huang, Yanqiu Shao, Michelle Xing, Eric J. Brandt, Diane E. MacDougall, Catherine D. Ahmed, Katherine A. Wilemon, Zahid Ahmad   +10 more
openaire   +1 more source

Exploring Medicaid claims data to understand predictors of healthcare utilization and mortality for Medicaid individuals with or without a diagnosis of lung cancer: a feasibility study

Translational Behavioral Medicine, 2018
Health disparities in low-income populations complicate care for at-risk individuals or those diagnosed with lung cancer and may influence their patterns of healthcare utilization. The purpose of this study is to examine whether age, sex, provider's affiliation, Medicare dual eligibility, and number of comorbidities can predict healthcare utilization ...
Darryl Somayaji, Yu-Ping Chang, Sabrina Casucci, Yuqing Xue, Sharon Hewner   +4 more
openaire   +2 more sources

^† Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Familial Hypercholesterolemia

Journal of Clinical Lipidology, 2023
Zahid Ahmad, Chao Xing, Amit Khera, Chun-Yuan Huang, Eric Brandt, Diane MacDougall, Cat Davis Ahmed, Mary McGowan, Katherine Wilemon, Kelly Myers   +9 more
openaire   +1 more source